|
Central Nervous System Fungal Infections
|
C01.207.198 |
|
|
Microbial Viability
|
G06.580 |
|
|
Sialography
|
E06.342.764.793 |
|
|
Glossopharyngeal Nerve
|
A08.800.050.600.387 |
|
|
Isophane Insulin, Human
|
D000068880 |
[Human isophane insulin that is used to manage BLOOD GLUCOSE levels in patients with DIABETES.
] |
|
Animals, Exotic
|
D000068881 |
[Animals native to a foreign country or of foreign origin or character, that are not native to the United States.
] |
|
Adalimumab
|
D000068879 |
[A humanized monoclonal antibody that binds specifically to TNF-ALPHA and blocks its interaction with endogenous TNF RECEPTORS to modulate INFLAMMATION. It is used in the treatment of RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS; CROHN'S DISEASE and ULCERATIVE COLITIS.
] |
|
Central Nervous System Bacterial Infections
|
C01.207.180 |
|
|
Concentration Camps
|
I01.880.604.787.358 |
|
|
Prisons
|
I01.880.604.787 |
|
|
Oligopeptides
|
D12.644.456 |
|
|
Fingolimod Hydrochloride
|
D000068876 |
[A sphingosine-derivative and IMMUNOSUPPRESSIVE AGENT that blocks the migration and homing of LYMPHOCYTES to the CENTRAL NERVOUS SYSTEM through its action on SPHINGOSINE 1-PHOSPHATE RECEPTORS. It is used in the treatment of MULTIPLE SCLEROSIS.
] |
|
Cortactin
|
D05.750.078.730.281 |
|
|
Imatinib Mesylate
|
D000068877 |
[A tyrosine kinase inhibitor and ANTINEOPLASTIC AGENT that inhibits the BCR-ABL kinase created by chromosome rearrangements in CHRONIC MYELOID LEUKEMIA and ACUTE LYMPHOBLASTIC LEUKEMIA, as well as PDG-derived tyrosine kinases that are overexpressed in gastrointestinal stromal tumors.
] |
|
Trastuzumab
|
D000068878 |
[A humanized monoclonal antibody against the ERBB-2 RECEPTOR (HER2). As an ANTINEOPLASTIC AGENT, it is used to treat BREAST CANCER where HER2 is overexpressed.
] |
|
Hemolysin Proteins
|
D12.776.543.695.444 |
|
|
Gentisates
|
D02.455.426.559.389.657.410.595.405 |
|
|
Candy
|
G07.203.300.140 |
|
|
Clioquinol
|
D03.633.100.810.350.625.400 |
|
|
Receptors, GABA
|
D12.776.543.750.720.200.300 |
|
